BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• BioMidwest

  Rebiotix Develops Microbiome Health Index to Identify Indicators for Microbiome Restoration

  Initial research indicates that Microbiome HealtMHI was established in partnership with data analytics firm, BioRankings, to enable a non-biased comparison of the efficacy of microbiome-based therapeutics.

  February 12, 2018

   · 

  4 min read
• Deals

  Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology

  The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community.

  February 12, 2018

   · 

  2 min read
• Business

  Palatin Technologies Reports Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018

  Palatin Technologies today announced results for its second quarter ended December 31, 2017.

  February 12, 2018

   · 

  17 min read
• BioCapital

  Immunomic to Participate at 2018 BIO CEO & Investor Conference with Presentation and Panel Discussion

  Immunomic announced today that the company will participate at the 2018 BIO CEO & Investor Conference in two events:

  February 12, 2018

   · 

  3 min read
• Business

  Applied Biomimetic Announces New Headquarters

  Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, announces the opening of its new headquarters and its research facilities in Gaithersburg, Maryland.

  February 12, 2018

   · 

  4 min read
• Drug Development

  Applied Therapeutics Initiates Phase I Trial for AT-001 In Diabetic Complications

  Applied today announced initiation of a Phase 1 clinical trial for AT-001, an oral small molecule in development for diabetic complications.

  February 12, 2018

   · 

  1 min read
• Drug Development

  Dermira Showcases Commitment to Hyperhidrosis Education and Treatment at Leading Dermatology Conference

  The event is taking place in San Diego, February 16-20.

  February 12, 2018

   · 

  7 min read
• Drug Development

  Pulmatrix Announces First Subject Dosed in Phase I Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole

  ABPA is a disease that occurs most often in patients with underlying asthma or cystic fibrosis, and it is characterized by an exaggerated allergic hypersensitivity response of the immune system to the fungus Aspergillus growing in the airways.

  February 12, 2018

   · 

  5 min read
• Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

  The alliance between Congenica and FutureNeuro, will further help the evolving understanding of the causes of many types of epilepsy and will also help to progress the exciting clinical alliance between genomics and electronic health records.

  February 12, 2018

   · 

  3 min read
• Drug Development

  Rexahn Reports Data From the Ongoing Phase IIa Clinical Trial of RX-3117 in Advanced Bladder Cancer at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting

  The poster presentation reported interim data on the Phase 2a clinical trial of RX-3117 monotherapy for the treatment of advanced bladder cancer.

  February 12, 2018

   · 

  6 min read